BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 20220841)

  • 21. [Theory for prophylactic AIDS vaccine development].
    Nomura T; Matano T
    Uirusu; 2009 Dec; 59(2):267-75. PubMed ID: 20218335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quest for an effective AIDS vaccine takes a new tack.
    Maurice J
    Lancet; 2011 Jul; 378(9787):213-4. PubMed ID: 21770060
    [No Abstract]   [Full Text] [Related]  

  • 23. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV/AIDS: waiting for a cure.
    Shearer WT
    J Allergy Clin Immunol; 2008 Jul; 122(1):34-5. PubMed ID: 18547632
    [No Abstract]   [Full Text] [Related]  

  • 25. [Development of an AIDS vaccine: status report].
    Girard MP
    Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
    Betts MR; Gray CM; Cox JH; Ferrari G
    Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccines against human immunodeficiency virus type 1.
    Estcourt MJ; McMichael AJ; Hanke T
    Immunol Rev; 2004 Jun; 199():144-55. PubMed ID: 15233732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
    Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
    J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
    [No Abstract]   [Full Text] [Related]  

  • 31. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappointing data scuttle plans for large-scale AIDS vaccine trial.
    Cohen J
    Science; 2002 Mar; 295(5560):1616-7. PubMed ID: 11872804
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
    Langlade-Demoyen P; Hoffenbach A
    Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA and the Ad5/HIV STEP trial.
    Hum Gene Ther; 2011 May; 22(5):517. PubMed ID: 21521071
    [No Abstract]   [Full Text] [Related]  

  • 35. AIDS 1989. Vaccines and immunology: overview.
    Laurence J; Schild GC
    AIDS; 1989; 3 Suppl 1():S97-100. PubMed ID: 2514762
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS response.
    Nature; 1991 Dec; 354(6353):439-40. PubMed ID: 1684222
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of mucosal immunity in development of an acquired immunodeficiency syndrome (AIDS) vaccine: workshop summary.
    Muul LM; Glass MJ; Wescott SL; Burkhardt AL; Koff WC; Strober WG
    Reg Immunol; 1989; 2(3):188-92. PubMed ID: 2701579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.
    Agwale SM; Shata MT; Reitz MS; Kalyanaraman VS; Gallo RC; Popovic M; Hone DM
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10037-41. PubMed ID: 12096189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the SIV model in AIDS vaccine research.
    Friedrich TC; Watkins DI
    IAVI Rep; 2005; 9(2):1, 6-8. PubMed ID: 16156073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.